Differential expression of BDNF mRNA splice variants in mouse brain and immune cells

Niels Kruse1, Seray Cetin, Andrew Chan

  • 1Institute for Multiple Sclerosis Research, Medical Faculty of University of Göttingen and Gemeinnützige Hertie-Stiftung, Waldweg 33, 37073 Göttingen, Germany.

Insights

Researchers found that only one brain-derived neurotrophic factor (BDNF) splice variant, mBDNF 3, is expressed in immune cells. This specific expression in immune cells, unlike the central nervous system (CNS), allows for targeted manipulation of BDNF in immunity.

Area of Science:

  • Neuroscience
  • Immunology
  • Molecular Biology

Background:

  • Brain-derived neurotrophic factor (BDNF) is crucial for neuronal development and function.
  • Several splice variants of BDNF mRNA have been identified.
  • The expression patterns of BDNF splice variants in the immune system are not well understood.

Purpose of the Study:

  • To investigate the expression of different BDNF mRNA splice variants in immune cells.
  • To compare BDNF splice variant expression in immune cells with that in the central nervous system (CNS).
  • To explore the potential for targeted manipulation of BDNF in immune responses.

Main Methods:

  • Analysis of mBDNF mRNA splice variant expression.
  • Comparison between immune cells (lymphoid organs, T cells, macrophages) and CNS tissue.
  • Assessment of mBDNF mRNA expression changes in activated T cells.

Main Results:

  • All mBDNF mRNA splice variants are expressed in the CNS.
  • Only mBDNF 3 mRNA variant was detected in primary and secondary lymphoid organs, T cells, and macrophages.
  • T cell activation upregulated mBDNF 3 mRNA expression without inducing other variants.

Conclusions:

  • mBDNF mRNA is differentially regulated in the CNS and the immune system.
  • The specific expression of mBDNF 3 in immune cells offers a potential target for therapeutic intervention.
  • Immune cell BDNF expression can be modulated without affecting global BDNF levels in the CNS.